Highly suppressive and non-toxic Trichosanthin-derived peptide induces skin transplantation tolerance via expanding CD4+CD25+Foxp3+ Tregs
lu liming,li qing,zhou lin,chou kuangyen
DOI: https://doi.org/10.3389/conf.fimmu.2013.02.00113
IF: 7.3
2013-01-01
Frontiers in Immunology
Abstract:Event Abstract Back to Event Highly suppressive and non-toxic Trichosanthin-derived peptide induces skin transplantation tolerance via expanding CD4+CD25+Foxp3+ Tregs Liming Lu1*, Qing Li1, Lin Zhou1 and Kuang-Yen Chou1 1 Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, China Trichosanthin (Tk), a component isolated from a Chinese medicinal herb Trichosanthes kirilowii, is active in abortifacient, anti-tumor, anti-HIV, as well as functions as an immune down-regulator. To separate its toxic property, a Tk-derived peptide Tk-PQ, containing forty C-terminal amino acids, was synthesized. We found that 10~50 mg/ml of Tk-PQ inhibited cell proliferation in a dose-dependent way without cytotoxicity as compared with native Tk. In the Tk-PQ-treated allogeneic mixed lymphocyte reaction, there were an increased production of IL-10/TGF-β and a decreased secretion of IFN-γ/IL-17A. Moreover, Tk-PQ promoted the activation of CD4+CD25+Foxp3+ Treg subset and remarkably increased the expression of interferon-regulatory factor 4 (IRF4). Pearson correlation analysis shows a significant positive correlation of IRF4 and Foxp3 expression (r=0.99; p=0.0003, n=5). Using murine full-thickness trunk skin allo-grafting model, we were able to show that Tk-PQ remarkably increased the survival of the allografts in the recipients from 9.0±1.1 days (control) to 22.2±2.8 days. Histological analysis of the allografts on day 9 post transplantation showed that the Tk-PQ treatment reduced the infiltration of mononuclear cells. The in vivo ratio of CD4+CD25+Foxp3+ Tregs was expanded in both spleen and peripheral blood of the recipients. Intracellular staining indicated that the percentages of IL-10+ cells were also increased in splenocytes and the CD4+CD25+Foxp3+ Treg population, while the IFN-γ+ cell percentages were decreased. Furthermore, Tk-PQ inhibited the phosphorylation of IκBα and the nuclear translocation of NF-B. These results indicate that Tk-PQ may have potential therapeutic values for the delay of graft rejection and the treatment of other inflammatory diseases. Acknowledgements This study was supported by grants from the National Natural Science Foundation of China (30972691), the Shanghai Young Qimingxing Talent Program Class A (10QA1405900), the Training Program of the Excellent Young Talents of the Shanghai Municipal Health System (XYQ2011015) and from the Shanghai Science-Technology Foundation (11JC1410802). Keywords: Trichosanthin-derived peptide, CD4+CD25+Foxp3+Treg, IRF4, transplantation tolerance of skin allo-grafts, immunotherapy of transplant rejection Conference: 15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013. Presentation Type: Abstract Topic: Translational immunology and immune intervention Citation: Lu L, Li Q, Zhou L and Chou K (2013). Highly suppressive and non-toxic Trichosanthin-derived peptide induces skin transplantation tolerance via expanding CD4+CD25+Foxp3+ Tregs. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00113 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 11 Mar 2013; Published Online: 22 Aug 2013. * Correspondence: Prof. Liming Lu, Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China, yukyeee@yahoo.cn Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Liming Lu Qing Li Lin Zhou Kuang-Yen Chou Google Liming Lu Qing Li Lin Zhou Kuang-Yen Chou Google Scholar Liming Lu Qing Li Lin Zhou Kuang-Yen Chou PubMed Liming Lu Qing Li Lin Zhou Kuang-Yen Chou Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.